Literature DB >> 19869716

REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : V. THE DEVELOPMENT OF EYE REACTIVITY TO DERIVATIVES OF PNEUMOCOCCI.

L A Julianelle1.   

Abstract

1. About two-thirds of the rabbits injected intracutaneously with suspensions of heat-killed S or R pneumococci develop an increased eye reactivity. 2. Eye reactions in these animals may be elicited by the instillation of "nucleoprotein," or of a solution of Pneumococcus from which the acid precipitable and heat coagulable proteins have been removed. The eye reactions are not elicited, under the conditions described, by living R cells or the protein-free, type-specific, polysaccharides. 3. Rabbits do not develop an increased eye reactivity following intravenous injections of the intact cell. 4. Rabbits do not develop an increased eye reactivity following injections of soluble derivatives of Pneumococcus. 5. Experimental infection by Pneumococcus may stimulate eye reactivity in rabbits. 6. Eye reactivity occurs in animals actively resistant to infection. 7. Eye reactions are observed more frequently in rabbits which show the secondary reaction.

Entities:  

Year:  1930        PMID: 19869716      PMCID: PMC2131840          DOI: 10.1084/jem.51.4.633

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : III. REACTIONS AT THE SITE OF INJECTION.

Authors:  L A Julianelle
Journal:  J Exp Med       Date:  1930-02-28       Impact factor: 14.307

2.  THE PRESENCE OF BACTERIA IN THE LUNGS OF MICE FOLLOWING INHALATION.

Authors:  E G Stillman
Journal:  J Exp Med       Date:  1923-07-31       Impact factor: 14.307

3.  REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : I. THE ANTIBODY RESPONSE.

Authors:  L A Julianelle
Journal:  J Exp Med       Date:  1930-02-28       Impact factor: 14.307

4.  REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : IV. THE DEVELOPMENT OF SKIN REACTIVITY TO DERIVATIVES OF PNEUMOCOCCUS.

Authors:  L A Julianelle
Journal:  J Exp Med       Date:  1930-03-31       Impact factor: 14.307

5.  REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : II. RESISTANCE TO INFECTION.

Authors:  L A Julianelle
Journal:  J Exp Med       Date:  1930-02-28       Impact factor: 14.307

6.  REACTIONS OF RABBITS TO NON-HEMOLYTIC STREPTOCOCCI : I. GENERAL TUBERCULIN-LIKE HYPERSENSITIVENESS, ALLERGY, OR HYPERERGY FOLLOWING THE SECONDARY REACTION.

Authors:  C L Derick; H F Swift
Journal:  J Exp Med       Date:  1929-03-31       Impact factor: 14.307

  6 in total
  6 in total

1.  EXPERIMENTAL ACUTE GLOMERULITIS.

Authors:  F D Lukens; W T Longcope
Journal:  J Exp Med       Date:  1931-03-31       Impact factor: 14.307

2.  REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : VIII. THE INTERRELATIONSHIPS OF HYPERSENSITIVENESS TO PNEUMOCOCCUS AND STREPTOCOCCUS.

Authors:  L A Julianelle; M C Morris
Journal:  J Exp Med       Date:  1932-05-31       Impact factor: 14.307

3.  HYPERSENSITIVENESS TO SOLUBLE SPECIFIC SUBSTANCES FROM YEAST-LIKE FUNGI : II. EYE HYPERSENSITIVITY.

Authors:  E Mott; H D Kesten
Journal:  J Exp Med       Date:  1931-05-31       Impact factor: 14.307

4.  REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : VI. HYPERSENSITIVENESS TO PNEUMOCOCCI AND THEIR PRODUCTS.

Authors:  L A Julianelle
Journal:  J Exp Med       Date:  1930-03-31       Impact factor: 14.307

5.  A TYPE SPECIFIC SUBSTANCE DISTINCT FROM THE SPECIFIC CARBOHYDRATE IN PNEUMOCOCCUS TYPE I.

Authors:  J F Enders
Journal:  J Exp Med       Date:  1930-07-31       Impact factor: 14.307

6.  REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : VII. THE RELATION OF HYPERSENSITIVENESS TO LESIONS IN THE LUNGS OF RABBITS INFECTED WITH PNEUMOCOCCI.

Authors:  L A Julianelle; C P Rhoads
Journal:  J Exp Med       Date:  1932-04-30       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.